NCT07817576Active, not recruiting
Serial Biomarker Testing and Cardiovascular Risk Stratification (ACHILLES)
Assessing Cardiovascular Hazard Via Intraindividual Biomarker Longitudinal Lability: an Evaluation of Serial Testing
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The goal of this observational study is to learn how blood levels of biomarkers, e.g. hsCRP and Lp(a) - two markers linked to heart disease risk - change over time in patients who have had these levels tested more than once. The main questions it aims to answer are: How often does a high result on a first test return to normal on a later test? Do patients whose levels stay high across repeated tests have a higher risk of death than patients whose high level was only temporary
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 110000 (actual)
- First submitted
- 2 Sept 2026
- Start date
- 1 Jan 2004
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- University Hospital Freiburg
- Diseases
- Heart failure
- NCT number
- NCT07817576
What you commit to
- Study type: Observational
- Participants enrolled: 110000
- From 1 Jan 2004 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \- \< 18 years, Biomarker not available
Who the study is looking for
- \- Available Biomarker Measurement
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology - Freiburg - Bad Krozingen Coordinator of this site? Confirm its status | Freiburg im Breisgau | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.